Perivascular adipose tissue in the pathogenesis of cardiovascular disease

Atherosclerosis

Volumn 230, Issue 2, 2013, Pages 177-184

  Lee, Hae Young ^a   Després, Jean Pierre ^b   Koh, Kwang Kon ^c  

^a Seoul National University College of Medicine   (South Korea)

^b LAVAL UNIVERSITY   (Canada)

^c Gachon University College of Medicine   (South Korea)

Author keywords

Cardiovascular disease; Perivascular adipose tissue; Risk factor

Indexed keywords

ADIPONECTIN; ADRENOMEDULLIN; ANGIOTENSIN II; ANGIOTENSINOGEN; C REACTIVE PROTEIN; CHEMERIN; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VASPIN;

ADIPOSE TISSUE; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BARIATRIC SURGERY; CARDIOVASCULAR RISK; DIAGNOSTIC PROCEDURE; EPICARDIAL ADIPOSE TISSUE; HUMAN; INTRAABDOMINAL FAT; PATHOGENESIS; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; WEIGHT REDUCTION;

CARDIOVASCULAR DISEASE; PERIVASCULAR ADIPOSE TISSUE; RISK FACTOR;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHEMOKINES; CYTOKINES; DIAGNOSTIC IMAGING; ENDOCRINE SYSTEM; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MYOCARDIUM; OBESITY; PERICARDIUM; RISK;

EID: 84884552994     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.07.037     Document Type: Review

References (86)

1. Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care 2011 May, 34(Suppl.2):S371-S379. [Review].
2. Gorter P.M., van Lindert A.S., de Vos A.M., et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008 Apr, 197(2):896-903. [Evaluation Studies Research Support, Non-U.S. Gov't].
3. Falk E., Thim T., Kristensen I.B. Atherosclerotic plaque, adventitia, perivascular fat, and carotid imaging. JACC Cardiovascular Imaging 2009 Feb, 2(2):183-186. [Comment Editorial].
4. Lau D.C., Dhillon B., Yan H., Szmitko P.E., Verma S. Adipokines: molecular links between obesity and atheroslcerosis. American Journal of Physiology Heart and Circulatory Physiology 2005 May, 288(5):H2031-H2041. [Research Support, Non-U.S. Gov't Review].
5. Chatterjee T.K., Stoll L.L., Denning G.M., et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circulation Research 2009 Feb 27, 104(4):541-549. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
6. Corradi D., Maestri R., Callegari S., et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovascular Pathology: The Official Journal of the Society for Cardiovascular Pathology 2004 Nov-Dec, 13(6):313-316.
7. Fain J.N., Sacks H.S., Bahouth S.W., Tichansky D.S., Madan A.K., Cheema P.S. Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat. Metabolism 2010 Sep, 59(9):1379-1386. [Research Support, Non-U.S. Gov't].
8. Gastaldelli A., Basta G. Ectopic fat and cardiovascular disease: what is the link?. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2010 Sep, 20(7):481-490. [Research Support, Non-U.S. Gov't Review].
9. Iacobellis G., Assael F., Ribaudo M.C., et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obesity Research 2003 Feb, 11(2):304-310. [Research Support, Non-U.S. Gov't].
10. Iozzo P., Lautamaki R., Borra R., et al. Contribution of glucose tolerance and gender to cardiac adiposity. The Journal of Clinical Endocrinology and Metabolism 2009 Nov, 94(11):4472-4482. [Research Support, Non-U.S. Gov't].
11. Mahabadi A.A., Massaro J.M., Rosito G.A., et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. European Heart Journal 2009 Apr, 30(7):850-856.
12. Verhagen S.N., Visseren F.L. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011 Jan, 214(1):3-10.
13. Seidell J.C., Bakker C.J., van der Kooy K. Imaging techniques for measuring adipose-tissue distribution - a comparison between computed tomography and 1.5-T magnetic resonance. American Journal of Clinical Nutrition 1990 Jun, 51(6):953-957. [Comparative Study].
14. Abbara S., Desai J.C., Cury R.C., Butler J., Nieman K., Reddy V. Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. European Journal of Radiology 2006 Mar, 57(3):417-422.
15. Park M.J., Jung J.I., Oh Y.S., Youn H.J. Assessment of epicardial fat volume with threshold-based 3-dimensional segmentation in CT: comparison with the 2-dimensional short axis-based method. Korean Circulation Journal 2010 Jul, 40(7):328-333.
16. van der Meer R.W., Doornbos J., Kozerke S., et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007 Oct, 245(1):251-257. [Comparative Study].
17. Kim S.J., Kim H.S., Jung J.W., Kim N.S., Noh C.I., Hong Y.M. Correlation between epicardial fat thickness by echocardiography and other parameters in obese adolescents. Korean Circulation Journal 2012 Jul, 42(7):471-478.
18. Wehrli N.E., Bural G., Houseni M., Alkhawaldeh K., Alavi A., Torigian D.A. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography. Seminars in Nuclear Medicine 2007 May, 37(3):195-205.
19. Judex S., Luu Y.K., Ozcivici E., Adler B., Lublinsky S., Rubin C.T. Quantification of adiposity in small rodents using micro-CT. Methods 2010 Jan, 50(1):14-19. [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.Review].
20. Kiessling F., Greschus S., Lichy M.P., et al. Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nature Medicine 2004 Oct, 10(10):1133-1138. [Comparative Study].
21. Thalmann S., Meier C.A. Local adipose tissue depots as cardiovascular risk factors. Cardiovascular Research 2007 Sep 1, 75(4):690-701. [Research Support, Non-U.S. Gov't Review].
22. Britton K.A., Fox C.S. Ectopic fat depots and cardiovascular disease. Circulation 2011 Dec 13, 124(24):e837-e841. [Research Support, N.I.H., Extramural Review].
23. Fabbrini E., Magkos F., Mohammed B.S., et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proceedings of the National Academy of Sciences of the United States of America 2009 Sep 8, 106(36):15430-15435. [Research Support, N.I.H., Extramural].
24. Campbell D.J., Habener J.F. Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 1987 Nov, 121(5):1616-1626. [Research Support, U.S. Gov't, P.H.S.].
25. Soltis E.E., Cassis L.A. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clinical and Experimental Hypertension Part A, Theory and Practice 1991, 13(2):277-296. [Research Support, U.S. Gov't, P.H.S.].
26. Lohn M., Dubrovska G., Lauterbach B., Luft F.C., Gollasch M., Sharma A.M. Periadventitial fat releases a vascular relaxing factor. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2002 Jul, 16(9):1057-1063. [InVitro Research Support, Non-U.S. Gov't].
27. Takaoka M., Suzuki H., Shioda S., et al. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 Aug, 30(8):1576-1582. [Research Support, Non-U.S. Gov't].
28. Chechi K., Blanchard P.G., Mathieu P., Deshaies Y., Richard D. Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease. International Journal of Cardiology 2012 Jun 22.
29. Greenstein A.S., Khavandi K., Withers S.B., et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009 Mar 31, 119(12):1661-1670. [Research Support, Non-U.S. Gov't].
30. Zhang H., Zhang C. Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. American Journal of Biomedical Sciences 2009 Apr 1, 1(2):133.
31. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007 Jan, 117(1):175-184. [Research Support, N.I.H., Extramural].
32. Iacobellis G., di Gioia C.R., Di Vito M., et al. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Hormone and Metabolic Research (Hormon- und Stoffwechselforschung - Hormones et metabolisme) 2009 Dec, 41(12):855-860.
33. Engeli S. Is there a pathophysiological role for perivascular adipocytes?. American Journal of Physiology Heart and Circulatory Physiology 2005 Nov, 289(5):H1794-H1795. [Comment Editorial].
34. Pang C., Gao Z., Yin J., Zhang J., Jia W., Ye J. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. American Journal of Physiology Endocrinology and Metabolism 2008 Aug, 295(2):E313-E322. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
35. Henrichot E., Juge-Aubry C.E., Pernin A., et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 Dec, 25(12):2594-2599. [Research Support, Non-U.S. Gov't].
36. Spiroglou S.G., Kostopoulos C.G., Varakis J.N., Papadaki H.H. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. Journal of Atherosclerosis and Thrombosis 2010 Feb 26, 17(2):115-130. [Research Support, Non-U.S. Gov't].
37. Rittig K., Staib K., Machann J., et al. Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 2008 Nov, 51(11):2093-2099. [Research Support, Non-U.S. Gov't].
38. Virdis A., Santini F., Colucci R., et al. Vascular generation of tumor necrosis factor-alpha reduces nitric oxide availability in small arteries from visceral fat of obese patients. Journal of American College of Cardiology 2011 Jul 12, 58(3):238-247. [InVitro Research Support, Non-U.S. Gov't].
39. Chen J.Y., Tsai P.J., Tai H.C., et al. Increased aortic stiffness and attenuated lysyl oxidase activity in obesity. Arteriosclerosis, Thrombosis, and Vascular Biology 2013 Apr, 33(4):839-846. [Research Support, Non-U.S. Gov't].
40. Koh K.K., Park S.M., Quon M.J. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008 Jun 24, 117(25):3238-3249. [Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Review].
41. Han S.H., Quon M.J., Kim J.A., Koh K.K. Adiponectin and cardiovascular disease: response to therapeutic interventions. Journal of American College Cardiology 2007 Feb 6, 49(5):531-538. [Review].
42. Lim S., Park Y.M., Sakuma I., Koh K.K. How to control residual cardiovascular risk despite statin treatment: focusing on HDL-cholesterol. International Journal of Cardiology 2012 Apr 12.
43. Iacobellis G., Pistilli D., Gucciardo M., et al. Adiponectin expression in human epicardial adipose tissue invivo is lower in patients with coronary artery disease. Cytokine 2005 Mar 21, 29(6):251-255.
44. Mazurek T., Zhang L., Zalewski A., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003 Nov 18, 108(20):2460-2466. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
45. Bays H.E. Adiposopathy is "sick fat" a cardiovascular disease?. Journal of American College Cardiology 2011 Jun 21, 57(25):2461-2473. [Research Support, Non-U.S. Gov't].
46. Cheng K.H., Chu C.S., Lee K.T., et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. International Journal of Obesity (London) 2008 Feb, 32(2):268-274. [Comparative Study].
47. Dandona M., Linehan D., Hawkins W., Strasberg S., Gao F., Wang-Gillam A. Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer. Pancreas 2011 Aug, 40(6):931-937.
48. Robinson S.T., Taylor W.R. Beyond the adventitia: exploring the outer limits of the blood vessel wall. Circulation Research 2009 Feb 27, 104(4):416-418. [Comment Editorial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.].
49. Barandier C., Montani J.P., Yang Z. Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. American Journal of Physiology Heart and Circulatory Physiology 2005 Nov, 289(5):H1807-H1813. [Research Support, Non-U.S. Gov't].
50. Langheim S., Dreas L., Veschini L., et al. Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. American Journal of Physiology Heart and Circulatory Physiology 2010 Mar, 298(3):H746-H753. [Research Support, Non-U.S. Gov't].
51. Hirata Y., Tabata M., Kurobe H., et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. Journal of American College of Cardiology 2011 Jul 12, 58(3):248-255. [Research Support, Non-U.S. Gov't].
52. Hirata Y., Kurobe H., Akaike M., et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. International Heart Journal 2011, 52(3):139-142. [Research Support, Non-U.S. Gov't].
53. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 Oct, 25(10):2054-2061. [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Review].
54. McGavock J.M., Lingvay I., Zib I., et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007 Sep 4, 116(10):1170-1175. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
55. Despres J.P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012 Sep 4, 126(10):1301-1313.
56. Rosito G.A., Massaro J.M., Hoffmann U., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008 Feb 5, 117(5):605-613. [Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
57. de Vos A.M., Prokop M., Roos C.J., et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. European Heart Journal 2008 Mar, 29(6):777-783. [Multicenter Study Research Support, Non-U.S. Gov't].
58. Wang C.P., Hsu H.L., Hung W.C., et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clinical Endocrinology 2009 Jun, 70(6):876-882. [Research Support, Non-U.S. Gov't].
59. Dey D., Wong N.D., Tamarappoo B., et al. Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and Metabolic Syndrome. Atherosclerosis 2010 Mar, 209(1):136-141.
60. Shin J.H. Is the measurement of epicardial fat in obese adolescents valuable?. Korean Circulation Journal 2012 Jul, 42(7):447-448.
61. Pou K.M., Massaro J.M., Hoffmann U., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007 Sep 11, 116(11):1234-1241. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
62. Sironi A.M., Petz R., De Marchi D., et al. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabetic Medicine: A Journal of the British Diabetic Association 2012 May, 29(5):622-627. [Research Support, Non-U.S. Gov't].
63. Baker A.R., Silva N.F., Quinn D.W., et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovascular Diabetology 2006, 5:1. [Randomized Controlled Trial Research Support, Non-U.S. Gov't].
64. Lee S.S., Wu T.L. The role of the mural coronary artery in prevention of coronary atherosclerosis. Archives of Pathology 1972 Jan, 93(1):32-35.
65. Fox C.S., Massaro J.M., Schlett C.L., et al. Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart study. Circulation Cardiovascular Imaging 2010 Sep, 3(5):515-519. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
66. Brinkley T.E., Hsu F.C., Carr J.J., et al. Pericardial fat is associated with carotid stiffness in the Multi-Ethnic Study of Atherosclerosis. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2011 May, 21(5):332-338. [Research Support, N.I.H., Extramural].
67. Park H.E., Choi S.Y., Kim H.S., Kim M.K., Cho S.H., Oh B.H. Epicardial fat reflects arterial stiffness: assessment using 256-slice multidetector coronary computed tomography and cardio-ankle vascular index. Journal of Atherosclerosis and Thrombosis 2012, 19(6):570-576.
68. Sironi A.M., Pingitore A., Ghione S., et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 2008 Feb, 51(2):282-288. [Research Support, Non-U.S. Gov't].
69. Rijzewijk L.J., van der Meer R.W., Smit J.W., et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. Journal of American College Cardiology 2008 Nov 25, 52(22):1793-1799. [Comparative Study].
70. Zhou Y.T., Grayburn P., Karim A., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proceedings of the National Academy of Sciences of the United States of America 2000 Feb 15, 97(4):1784-1789. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
71. Tuunanen H., Engblom E., Naum A., et al. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction. Journal of Cardiac Failure 2006 Oct, 12(8):644-652. [Research Support, Non-U.S. Gov't].
72. Fox C.S., Gona P., Hoffmann U., et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 2009 Mar 31, 119(12):1586-1591. [Research Support, N.I.H., Extramural].
73. Thanassoulis G., Massaro J.M., O'Donnell C.J., et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circulation Arrhythmia and Electrophysiology 2010 Aug, 3(4):345-350. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
74. Bodenant M., Kuulasmaa K., Wagner A., et al. Measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. Stroke 2011 Oct, 42(10):2872-2877. [Research Support, Non-U.S. Gov't].
75. Mathieu P., Despres J.P., Pibarot P. The 'valvulo-metabolic' risk in calcific aortic valve disease. The Canadian Journal of Cardiology 2007 Oct, 23(Suppl.B):32B-39B. [Research Support, Non-U.S. Gov't Review].
76. Iacobellis G., Singh N., Wharton S., Sharma A.M. Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) 2008 Jul, 16(7):1693-1697. [Clinical Trial Research Support, Non-U.S. Gov't].
77. Nakazato R., Rajani R., Cheng V.Y., et al. Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis 2012 Jan, 220(1):139-144. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
78. Snel M., Jonker J.T., Hammer S., et al. Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients. Obesity (Silver Spring) 2012 Aug, 20(8):1572-1576. [Research Support, Non-U.S. Gov't].
79. Gaborit B., Jacquier A., Kober F., et al. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. Journal of American College Cardiology 2012 Oct 9, 60(15):1381-1389.
80. Sacks H.S., Fain J.N., Cheema P., et al. Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care 2011 Mar, 34(3):730-733. [Research Support, Non-U.S. Gov't].
81. Jonker J.T., Lamb H.J., van der Meer R.W., et al. Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism 2010 Jan, 95(1):456-460. [Randomized Controlled Trial Research Support, Non-U.S. Gov't].
82. Alexopoulos N., Melek B.H., Arepalli C.D., et al. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES Trial (Beyond Endorsed Lipid Lowering with EBT Scanning). Journal of American College Cardiology 2013 May 14, 61(19):1956-1961.
83. Wu Y.W., Kao H.L., Huang C.L., et al. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. European Journal of Nuclear Medicine and Molecular Imaging 2012 Mar, 39(3):399-407. [Clinical Trial Research Support, Non-U.S. Gov't].
84. Khan T., Hamilton M.P., Mundy D.I., Chua S.C., Scherer P.E. Impact of simvastatin on adipose tissue: pleiotropic effects invivo. Endocrinology 2009 Dec, 150(12):5262-5272. [Research Support, N.I.H., Extramural].
85. Park J.H., Park Y.S., Kim Y.J., et al. Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. Journal of Cardiovascular Ultrasound 2010 Dec, 18(4):121-126.
86. Takase H., Dohi Y., Okado T., Hashimoto T., Goto Y., Kimura G. Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study. European Journal of Clinical Investigation 2012 Dec, 42(12):1287-1294. [Randomized Controlled Trial].